Pages that link to "Q44682791"
The following pages link to Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study (Q44682791):
Displaying 50 items.
- Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infants (Q24194676) (← links)
- Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants (Q24194710) (← links)
- Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants (Q24240398) (← links)
- Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants (Q24241263) (← links)
- Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants (Q24250213) (← links)
- Outcomes of children of extremely low birthweight and gestational age in the 1990's (Q33544232) (← links)
- Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia (Q33623353) (← links)
- Multicentre randomised trial comparing high and low dose surfactant regimens for the treatment of respiratory distress syndrome (the Curosurf 4 trial) (Q33623794) (← links)
- Growth retardation after dexamethasone administration: assessment by knemometry (Q33623976) (← links)
- Static respiratory compliance in the newborn. I: A clinical and prognostic index for mechanically ventilated infants (Q33706210) (← links)
- Surfactant phosphatidylcholine composition during dexamethasone treatment in chronic lung disease (Q33706562) (← links)
- Intravenous nutrition and postnatal growth of the micropremie (Q33847878) (← links)
- Postnatal corticosteroids in preterm infants: systematic review of effects on mortality and motor function (Q33888778) (← links)
- Dexamethasone therapy in chronic lung disease (Q33929177) (← links)
- Postnatal glucocorticosteroid therapy for treatment and prevention of neonatal chronic lung disease (Q34074665) (← links)
- Perinatal immunomodulation (Q34975564) (← links)
- Effects of antenatal and postnatal corticosteroids on the preterm lung (Q35286022) (← links)
- Open randomised controlled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants (Q35286092) (← links)
- Prediction of individual response to postnatal dexamethasone in ventilator dependent preterm infants (Q35286894) (← links)
- Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease (Q35287062) (← links)
- Cerebral haemodynamics in preterm infants after exposure to dexamethasone (Q35287363) (← links)
- Early postnatal dexamethasone treatment and increased incidence of cerebral palsy (Q35290082) (← links)
- Postnatal corticosteroids for prevention and treatment of chronic lung disease in the preterm newborn (Q35294711) (← links)
- Measurement of pulmonary status and surfactant protein levels during dexamethasone treatment of neonatal respiratory distress syndrome (Q36500274) (← links)
- Early cortisol values and long-term outcomes in extremely low birth weight infants (Q36650359) (← links)
- Paediatrics--Part I. (Q36683473) (← links)
- Babies born under 1000 g--perinatal outcome. (Q36750868) (← links)
- Pulse dexamethasone does not impair growth and body composition of very low birth weight infants (Q36786406) (← links)
- Failure of early postnatal dexamethasone to prevent chronic lung disease in infants with respiratory distress syndrome (Q36859749) (← links)
- Increase in interleukin-8 and soluble intercellular adhesion molecule-1 in bronchoalveolar lavage fluid from premature infants who develop chronic lung disease (Q36859964) (← links)
- Dexamethasone retrodialysis attenuates microglial response to implanted probes in vivo. (Q36899857) (← links)
- Understanding intestinal vulnerability to perforation in the extremely low birth weight infant (Q37267187) (← links)
- The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia (Q38365940) (← links)
- New aerosol delivery system for neonatal ventilator circuits (Q38366065) (← links)
- Respiratory Support for Very Low Birth Weight Infants Receiving Dexamethasone (Q40370995) (← links)
- Bronchoalveolar Inflammatory Pathophysiology of Bronchopulmonary Dysplasia (Q40480499) (← links)
- Adrenocortical function in the very low birth weight infant: improved testing sensitivity and association with neonatal outcome (Q40990222) (← links)
- The role of corticosteroids in respiratory diseases of children (Q41151318) (← links)
- Strategies to prevent chronic neonatal lung disease (Q41328637) (← links)
- Intratracheal Administration of Budesonide/Surfactant to Prevent Bronchopulmonary Dysplasia (Q41385582) (← links)
- Markers and mediators of inflammation in neonatal lung disease (Q41462532) (← links)
- Bronchopulmonary dysplasia in the 1990s: a review for the pediatrician (Q41465989) (← links)
- Randomised controlled study of early use of inhaled corticosteroid in preterm infants with respiratory distress syndrome (Q42096475) (← links)
- Prediction of chronic lung disease (CLD) (Q42425725) (← links)
- Dexamethasone associated systemic hypertension in low birth weight babies with chronic lung disease (Q42553714) (← links)
- Acute pathophysiological effects of intratracheal instillation of budesonide and exogenous surfactant in a neonatal surfactant-depleted piglet model (Q42936198) (← links)
- Bronchopulmonary dysplasia and corticosteroid therapy (Q43934230) (← links)
- Adrenal suppression and extubation rate after moderately early low-dose dexamethasone therapy in very preterm infants (Q44598125) (← links)
- Dexamethasone dosing, mechanical ventilation and the risk of cerebral palsy (Q44917488) (← links)
- Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: a possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns. (Q46011333) (← links)